GUJARAT KIDNEY AND SUPER SPECIALITY
|
GUJARAT KIDNEY AND SUPER SPECIALITY Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 1.97 | 1.66 | 85.70 | -0.31 | 5.00 |
| CEPS(Rs) | 2.73 | 2.25 | 0.58 | - | 0.19 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 32.03 | 4.56 | 87.03 | 18.51 | 18.83 |
| Tax Rate(%) | 20.83 | 25.58 | 24.44 | - | 26.85 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 32.85 | 41.12 | 40.86 | - | - |
| EBIT Margin(%) | 28.18 | 33.33 | 48.92 | - | - |
| Pre Tax Margin(%) | 25.89 | 31.72 | 47.51 | - | - |
| PAT Margin (%) | 20.50 | 23.61 | 35.90 | - | - |
| Cash Profit Margin (%) | 26.23 | 31.78 | 42.59 | - | - |
| Performance Ratios | |||||
| ROA(%) | 9.61 | 25.28 | 14.09 | -0.16 | 2.61 |
| ROE(%) | 12.08 | 68.65 | 162.40 | -1.66 | 26.56 |
| ROCE(%) | 15.51 | 63.02 | 35.61 | -1.66 | 36.31 |
| Asset Turnover(x) | 0.47 | 1.07 | 0.39 | - | - |
| Sales/Fixed Asset(x) | 0.87 | 1.58 | 0.34 | - | - |
| Working Capital/Sales(x) | 1.07 | 274.69 | 1.92 | - | - |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.15 | 0.63 | 2.92 | - | - |
| Receivable days | 119.68 | 87.78 | 204.57 | - | - |
| Inventory Days | 6.08 | 4.29 | 20.64 | - | - |
| Payable days | 234.33 | 250.56 | 3,365.79 | - | - |
| Valuation Parameters | |||||
| PER(x) | 51.51 | - | - | - | - |
| PCE(x) | 37.11 | - | - | - | - |
| Price/Book(x) | 3.16 | - | - | - | - |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 9.24 | 0.31 | 0.20 | - | - |
| EV/Core EBITDA(x) | 27.24 | 0.74 | 0.36 | -31.69 | 0.28 |
| EV/EBIT(x) | 32.78 | 0.93 | 0.41 | -31.69 | 1.44 |
| EV/CE(x) | 2.82 | 0.42 | 0.08 | 0.53 | 0.52 |
| M Cap / Sales | 9.73 | - | - | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 103.80 | 742.89 | - | - | - |
| Core EBITDA Growth(%) | 66.52 | 529.12 | - | -100.87 | - |
| EBIT Growth(%) | 72.34 | 474.25 | - | -104.54 | - |
| PAT Growth(%) | 76.98 | 454.22 | - | -106.20 | - |
| EPS Growth(%) | 18.69 | -98.07 | - | -106.20 | - |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.06 | 0.15 | 1.12 | - | - |
| Current Ratio(x) | 3.76 | 1.01 | 1.59 | 0.33 | 0.33 |
| Quick Ratio(x) | 3.69 | 0.98 | 1.52 | 0.33 | 0.33 |
| Interest Cover(x) | 12.31 | 20.75 | 34.75 | - | - |
| Total Debt/Mcap(x) | 0.02 | - | - | - | - |
Compare Financial Ratios of peers of GUJARAT KIDNEY AND SUPER SPECIALITY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT KIDNEY AND SUPER SPECIALITY | ₹1,403.4 Cr | -2.8% | 17% | NA | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹127,823.0 Cr | -0.6% | 1.1% | 14% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹98,693.7 Cr | -4.7% | 0.2% | -9.8% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹66,181.7 Cr | 0.4% | -0.4% | 17.9% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹63,046.6 Cr | -6.9% | -9% | -8% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹38,040.7 Cr | -1.8% | -1.2% | 5.6% | Stock Analytics | |
GUJARAT KIDNEY AND SUPER SPECIALITY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT KIDNEY AND SUPER SPECIALITY | -2.8% |
17% |
|
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses
